BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35757692)

  • 21. Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle.
    Cecílio P; Oristian J; Meneses C; Serafim TD; Valenzuela JG; Cordeiro da Silva A; Oliveira F
    Sci Rep; 2020 Oct; 10(1):18653. PubMed ID: 33122717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major-infected BALB/c mice.
    Montakhab-Yeganeh H; Abdossamadi Z; Zahedifard F; Taslimi Y; Badirzadeh A; Saljoughian N; Taheri T; Taghikhani M; Rafati S
    Parasite Immunol; 2017 Oct; 39(10):. PubMed ID: 28833211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model.
    Wheat WH; Arthun EN; Spencer JS; Regan DP; Titus RG; Dow SW
    Vaccine; 2017 Dec; 35(48 Pt B):6611-6619. PubMed ID: 29079105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model.
    Gomes R; Teixeira C; Teixeira MJ; Oliveira F; Menezes MJ; Silva C; de Oliveira CI; Miranda JC; Elnaiem DE; Kamhawi S; Valenzuela JG; Brodskyn CI
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7845-50. PubMed ID: 18509051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania.
    Collin N; Gomes R; Teixeira C; Cheng L; Laughinghouse A; Ward JM; Elnaiem DE; Fischer L; Valenzuela JG; Kamhawi S
    PLoS Pathog; 2009 May; 5(5):e1000441. PubMed ID: 19461875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Leishmanization Using
    Keshavarzian N; Noroozbeygi M; Haji Molla Hoseini M; Yeganeh F
    Front Immunol; 2020; 11():1725. PubMed ID: 33193290
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.
    Saljoughian N; Taheri T; Zahedifard F; Taslimi Y; Doustdari F; Bolhassani A; Doroud D; Azizi H; Heidari K; Vasei M; Namvar Asl N; Papadopoulou B; Rafati S
    PLoS Negl Trop Dis; 2013; 7(4):e2174. PubMed ID: 23638195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.
    Francesquini FC; Silveira FT; Passero LF; Tomokane TY; Carvalho AK; Corbett CE; Laurenti MD
    Int J Exp Pathol; 2014 Dec; 95(6):418-26. PubMed ID: 25476864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum.
    Pirdel L; Farajnia S
    Scand J Immunol; 2017 Jul; 86(1):15-22. PubMed ID: 28426153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi.
    Gomes R; Teixeira C; Oliveira F; Lawyer PG; Elnaiem DE; Meneses C; Goto Y; Bhatia A; Howard RF; Reed SG; Valenzuela JG; Kamhawi S
    PLoS Negl Trop Dis; 2012; 6(4):e1610. PubMed ID: 22509423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.
    Mizbani A; Taheri T; Zahedifard F; Taslimi Y; Azizi H; Azadmanesh K; Papadopoulou B; Rafati S
    Vaccine; 2009 Dec; 28(1):53-62. PubMed ID: 19818721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Live attenuated Leishmania major p27 gene knockout as a novel vaccine candidate: A study on safety, protective immunity and efficacy against canine leishmaniasis caused by Leishmania infantum.
    Elikaee S; Zarei Z; Khamesipour A; Akhoundi B; Borjian AR; Afshar MJA; Allely QK; Heidari S; Mohebali M
    Acta Trop; 2022 Jan; 225():106153. PubMed ID: 34634264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
    Shahbazi M; Zahedifard F; Taheri T; Taslimi Y; Jamshidi S; Shirian S; Mahdavi N; Hassankhani M; Daneshbod Y; Zarkesh-Esfahani SH; Papadopoulou B; Rafati S
    PLoS One; 2015; 10(7):e0132794. PubMed ID: 26197085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis Infection.
    Gomes R; Cavalcanti K; Teixeira C; Carvalho AM; Mattos PS; Cristal JR; Muniz AC; Miranda JC; de Oliveira CI; Barral A
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005078. PubMed ID: 27812113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae).
    Anjili C; Langat B; Ngumbi P; Mbati PA; Githure J; Tonui WK
    East Afr Med J; 2006 Feb; 83(2):72-8. PubMed ID: 16708877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum.
    Habibzadeh S; Doroud D; Taheri T; Seyed N; Rafati S
    Iran Biomed J; 2021 Sep; 25(5):349-58. PubMed ID: 34481426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promastigote secretory gel from natural and unnatural sand fly vectors exacerbate
    Giraud E; Svobodová M; Müller I; Volf P; Rogers ME
    Parasitology; 2019 Dec; 146(14):1796-1802. PubMed ID: 31452467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histologic characterization of experimental cutaneous leishmaniasis in mice infected with Leishmania braziliensis in the presence or absence of sand fly vector salivary gland lysate.
    Donnelly KB; Lima HC; Titus RG
    J Parasitol; 1998 Feb; 84(1):97-103. PubMed ID: 9488345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.
    Oliveira F; Rowton E; Aslan H; Gomes R; Castrovinci PA; Alvarenga PH; Abdeladhim M; Teixeira C; Meneses C; Kleeman LT; Guimarães-Costa AB; Rowland TE; Gilmore D; Doumbia S; Reed SG; Lawyer PG; Andersen JF; Kamhawi S; Valenzuela JG
    Sci Transl Med; 2015 Jun; 7(290):290ra90. PubMed ID: 26041707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva.
    de Moura TR; Oliveira F; Novais FO; Miranda JC; Clarêncio J; Follador I; Carvalho EM; Valenzuela JG; Barral-Netto M; Barral A; Brodskyn C; de Oliveira CI
    PLoS Negl Trop Dis; 2007 Nov; 1(2):e84. PubMed ID: 18060088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.